The patient was followed-up for four years without any sequel.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Henoch-Schönlein purpura is a common form of systemic small vessel vasculitis in childhood.
📊
Temel Bulgular & Veri:Although headache and behavioral changes have been described in a significant proportion of children with Henoch-Schönlein purpura, severe neurological complications are rare.
💡
Sonuç & Katkı:The patient was followed-up for four years without any sequel.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
Henoch-Schönlein purpura is a common form of systemic small vessel vasculitis in childhood. Although headache and behavioral changes have been described in a significant proportion of children with Henoch-Schönlein purpura, severe neurological complications are rare. In this article, we report a case of central vasculitis in a four-year-old boy who presented with hemiplegia and aphasia. The treatment options for cerebral vasculitis of Henoch-Schönlein purpura are numerous but controversial in pediatric patients. Our patient was successfully treated by pulse methylprednisolone and pulse cyclophosphamide. The patient was followed-up for four years without any sequel.
🔖
Bu Makaleye Atıf Yap
AKÇABOY, M., FİDAN, H. K., KANDUR, Y., ISIYEL, E., BÜYÜKKARAGÖZ, B., EZGÜ, S. A. B., BUYAN, N., HASANOĞLU, E., SÖYLEMEZOĞLU, O. (2017). Cerebral Vasculitis in Henoch-Schönlein Purpura: A Case Report. art, Cilt: 32 - Sayı: 3, 264–267. https://ajindex.com/articles/351724
Weiss PF. Pediatric vasculitis. Pediatr Clin North Am 2012;59:407-23
Deng F, Lu L, Zhang Q, Hu B, Wang SJ, Huang N. Henoch-Schönlein purpura in childhood: treatment and prognosis. Analysis of 425 cases over a 5-year period. Clin Rheumatol 2010;29:369-74
Bakkalo¤lu SA, Ekim M, Tümer N, Deda G, Erden I, Erdem T. Cerebral vasculitis in Henoch-Schönlein purpura. Nephrol Dial Transplant 2000;15:246-8
Garzoni L, Vanoni F, Rizzi M, Simonetti GD, Goeggel Simonetti B, Ramelli GP, et al. Nervous system dysfunction in Henoch-Schonlein syndrome: systematic review of the literature. Rheumatology (Oxford) 2009;48:1524-9
McCarthy HJ, Tizard EJ. Clinical practice: Diagnosis and management of Henoch-Schönlein purpura. Eur J Pediatr 2010;169:643-50
Ostergaard JR, Storm K. Neurologic manifestations of Schönlein-Henoch purpura. Acta Paediatr Scand 1991;80:339-42
Belman AL, Leicher CR, Moshé SL, Mezey AP. Neurologic manifestations of Schoenlein-Henoch purpura: report of three cases and review of the literature. Pediatrics 1985;75:687-92
Eun SH, Kim SJ, Cho DS, Chung GH, Lee DY, Hwang PH. Cerebral vasculitis in Henoch-Schönlein purpura: MRI and MRA findings, treated with plasmapheresis alone. Pediatr Int 2003;45:484-7
Yüksel S, Ça¤lar M, Evrengül H, Becerir T, Tepeli E, Ergin A, et al. Could serum pentraxin 3 levels and IgM deposition in skin biopsies predict subsequent renal involvement in children with Henoch-Schönlein purpura? Pediatr Nephrol 2015;30:969-74
Wen YK, Yang Y, Chang CC. Cerebral vasculitis and intracerebral hemorrhage in Henoch-Schönlein purpura treated with plasmapheresis. Pediatr Nephrol 2005;20:223-5